We are live on ! Find out more
VIGL

Vigil Neuroscience

Delisted

VIGL was delisted on the 4th of August, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$54.9M
NV
2
Northpond Ventures
Maryland
$39.6M
Citadel Advisors
3
Citadel Advisors
Florida
$20.5M +$175K +18,528 +0.9%
DM
4
Deerfield Management
New York
$19.3M
AG
5
Artal Group
Luxembourg
$18M -$3.14M -332,161 -15%
BI
6
BVF Inc
California
$17M
DTC
7
Deep Track Capital
Connecticut
$16.7M -$2.38M -251,728 -12%
BlackRock
8
BlackRock
New York
$7.72M +$6.8M +719,366 +705%
Vanguard Group
9
Vanguard Group
Pennsylvania
$7.45M +$602K +63,623 +9%
CAM
10
Cormorant Asset Management
Massachusetts
$5.8M
PBPIA
11
Pivotal bioVenture Partners Investment Advisor
California
$5.27M
RSCM
12
Rock Springs Capital Management
Maryland
$4.44M
O
13
OrbiMed
New York
$4.22M
HMC
14
Harvard Management Company
Massachusetts
$2.72M
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.68M +$1.63M +172,451 +153%
State Street
16
State Street
Massachusetts
$2.44M +$2.12M +223,960 +627%
TOCUITCONY
17
Trustees of Columbia University in the City of New York
New York
$1.81M
LGM
18
Logos Global Management
California
$1.77M
DCM
19
DAFNA Capital Management
California
$1.62M
Fidelity Investments
20
Fidelity Investments
Massachusetts
$1.32M +$507K +53,676 +62%
Northern Trust
21
Northern Trust
Illinois
$1.17M +$966K +102,127 +459%
Barclays
22
Barclays
United Kingdom
$986K +$6.18K +654 +0.6%
LCM
23
Laurion Capital Management
New York
$937K -$288K -30,511 -23%
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$728K +$302K +31,950 +77%
Citigroup
25
Citigroup
New York
$649K -$211K -22,321 -24%